Dow Down 0.18% Nasdaq Up 0.39%

Lexicon Pharmaceuticals, Inc. (LXRX)

-NasdaqGS
1.51 Down 0.01(0.66%) 4:15PM EDT
|After Hours : 1.51 0.00 (0.00%) 4:30PM EDT
Prev Close:1.52
Open:1.54
Bid:1.47 x 3000
Ask:1.57 x 6500
1y Target Est:3.05
Beta:2.47
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:1.50 - 1.57
52wk Range:1.25 - 3.18
Volume:734,854
Avg Vol (3m):1,200,820
Market Cap:777.38M
P/E (ttm):N/A
EPS (ttm):-0.21
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
LXRXDown 0.66%777.38M
DGEN 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):300.85
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.20
Quarterly EPS Est (Sep-14) :-0.05
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):-0.24

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for human disease. Its drug development programs include LX4211, an orally-delivered small molecule compound that has completed two Phase II clini... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback